KalVista Pharmaceuticals

-$0.35 (-1.70%) As of 4:52 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell KALV and other ETFs, options, and stocks.

About KALV

KalVista Pharmaceuticals, Inc. is a clinical stage pharmaceutical company, which engages in the discovery, development, and commercialization of small molecule protease inhibitors. Its product candidates are inhibitors of plasma kallikrein being developed for two indications: hereditary angioedema (HAE) and diabetic macular edema (DME).

CEO
T. Andrew Crockett
Employees
70
Headquarters
Cambridge, Massachusetts
Founded
2004

KALV Key Statistics

Market Cap
675.84M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
229.42K
High Today
$20.86
Low Today
$20.12
Open Price
$20.68
Volume
28.25K
52 Week High
$45.00
52 Week Low
$9.62

KALV Earnings

-$0.65
-$0.43
-$0.22
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Estimated
— per share
Actual
Expected Sep 14, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure